Lucanthone
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. (November 2012) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 1-{[2-(diethylamino)ethyl]amino}-4-methyl-9H-thioxanthen-9-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 479-50-5  |
| ATC code | None |
| PubChem | CID 10180 |
| DrugBank | DB04967 |
| ChemSpider | 9772  |
| UNII | FC6D57000M |
| ChEBI | CHEBI:51052 |
| Chemical data | |
| Formula | C20H24N2OS |
| Mol. mass | 340.48 g/mol |
 (what is this?) (verify) |
|
Lucanthone is a drug used in chemotherapy. It is a prodrug and is converted to an active metabolite "hycanthone".
Mechanism of action [edit]
Hycanthone binds to acetylcholine receptors in the worm and results in increased sensitivity to stimulation by 5-HT causing increase in motility, paired worms are separated and reproduction is stopped. It cause damage of the integument and vitelline duct.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
